FDA recall D-245-2013

Teva Pharmaceuticals USA, Inc. · Class III · drug

Product

Portia (levonorgestrel and ethinyl estradiol) Tablets, USP, 0.15 mg/0.03 mg, 28-count tablets (containing 21 pink tablets followed by 7 white tablets) per blister card packaged in 6 blister cards per carton, Rx only, Barr Laboratories, Inc., Pomona, NY 10970, NDC 0555-9020-58.

Reason for recall

Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance.

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2013-03-12
Report date
2013-04-17
Termination date
2014-01-15
Voluntary/Mandated
Voluntary: Firm initiated
Location
Sellersville, PA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-245-2013